CMS proposes changes to increase Medicaid drug price transparency  

May 25, 2023 - 02:51 PM
stock-doctor-prescription-bottles_900x400

The Centers for Medicare & Medicaid Services this week proposed changes to the Medicaid Drug Rebate Program intended to improve manufacturer data integrity and help states verify drug prices. CMS will accept comments on the proposed rule through July 25. 

Related News Articles

Perspective
Speaking Up for Priorities That Will Help Hospitals Advance Health for Patients and Communities
It’s an understatement to say everything on the national political scene is both unprecedented and unpredictable these days.To state the obvious, there will be…
Headline
In advance of IPPS final rule, AHA urges CMS not to cut DSH payments 
The AHA July 25 urged the Centers for Medicare & Medicaid Services to maintain the uninsured rate at 8.7% under the inpatient prospective payment system…
Headline
HHS authorizes five states to provide health care coverage for people transitioning out of incarceration 
The Department of Health and Human Services July 2 announced it will provide Medicaid and Children's Health Insurance Program coverage to incarcerated people…
Headline
MACPAC recommends increased transparency on Medicaid and CHIP financing 
The Medicaid and CHIP Payment and Access Commission (MACPAC) June 11 released its June report to Congress. The first chapter focuses on improving the…
Headline
GAO report finds lack of oversight on Medicaid managed care plans’ prior authorization requirements for children
A report released May 29 by the Government Accountability Office found a lack of state oversight on Medicaid managed care plans’ use of prior authorization for…
Headline
CMS seeks comments on information associated with attestation requirements included in Medicaid managed care access rule
The Centers for Medicare & Medicaid Services is seeking public comments until July 22 on the information requirements associated with attestation…